Previous: CEO foreword
The August 2025
collection covers around
57 per cent of Australia’s
population – about
14.5 million Australians.
Record highs
December 2024
August 2025
|
|
October 2025
|
|
|
Likely future trends
There is potential for further increases in methylamphetamine and cocaine consumption. Heroin consumption continues to fluctuate and there are indications that consumption of MDMA may have plateaued.
Further increase
|
|
Fluctuation
Plateaued
Yearly estimated consumption
Methylamphetamine
Cocaine
MDMA
Heroin
Estimated state and territory consumption for Year 9 of the Program
Methylamphetamine
Cocaine
MDMA
Heroin
Year 9 trends
Between Year 8 and 9 of the Program
(August 2024 to August 2025)
total estimated consumption of
methylamphetamine, cocaine, MDMA
and heroin increased by 4.6 tonnes,
or 21 per cent of the combined weight.
Market impacts
Consumption of methylamphetamine, cocaine, MDMA and heroin increased 23%, 17%, 20% and 23% respectively.
Market value
The estimated street value
of the 4 drugs in Year 9 was
a record $14.3 billion, up from
$11.5 billion in Year 8.
International drug consumption comparisons 2024
Methylamphetamine consumption in Australia ranked 2nd of 34 SCORE* countries
Cocaine consumption in Australia ranked 24th of 34 SCORE* countries
MDMA consumption in Australia ranked 12th of 33 SCORE* countries
Cannabis consumption in Australia ranked 7th of 26 SCORE* countries
*SCORE – Sewage Core Group Europe covering Europe, North and South America and Oceania.
Next: Introduction